Know More About “Single-Cell Genome Sequencing Market 2025” Growth Worldwide…..|Grand View Research, Inc.

Posted by Mrudula Anil Karmarkar on May 23rd, 2023

The global single-cell genome sequencing market size is expected to reach USD 2.49 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 14.64% during the forecast period. Advancements in the field of single-cell analysis are anticipated to boost the growth of the market in the coming years.

Moreover, active participation and contribution of market players toward product upgradation are playing an important role in the growth of the market. Increasing number of collaborations and strategic alliances between companies are fostering the development of a collaborative portfolio in the system.

Moreover, emergence of next-generation sequencing (NGS) has helped the market gain tremendous traction over the past few years. Earlier, single-cell genome sequencing market was dominated by PCR and microarray technologies. However, qPCR and NGS are increasingly emerging as the preferred technologies.

Furthermore, rising number of single-cell genome sequencing centers & associated facilities worldwide is fostering growth prospects. The main objective of such entities is to develop novel single-cell genome sequencing-based applications and methods. These centers are also playing a major role in introducing advanced tools & instruments for scientific communities of various regions. This, in turn, is helping augmenting growth opportunities for the market.

In addition, public-private collaborations among governments, companies, and research institutions in the space are expected to promote more research initiatives. Various funding grants by NIH and private players such as Mission Bio are escalating the growth of the market.

Increasing R&D activities, rising incidence of chronic & severe immune system disorders and cancer, and growing focus of companies on product development are among the key trends triggering market growth. Moreover, supportive government policies are expected to boost the progress of the market over the forecast period.

Technological advancements in the field of single-cell genome sequencing are playing an instrumental role in the development of the market. Recently, Bio-Rad Laboratories, Inc. and Illumina, Inc. collaborated to develop an innovative workflow for SCGS analysis. They recently announced the launch of SCGS solution. The technologically advanced platforms offer intuitive analysis software solutions and are cost-effective in nature.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/single-cell-genome-sequencing-market/request/rs1

Moreover, supportive government policies are expected to boost the progress of the market over the forecast period. Rising number of genomics centers is also estimated to drive the market. Various established centers are working and eventually accelerating advancements through collaborative activities.

Various participants including Qiagen and Illumina, Inc. are developing and manufacturing NGS-based platforms and tools, such as SCGS-related bioinformatics and sampling, in order to address the surging demand for rapid and efficient sequencers. NGS platform allows parallel sequencing of multiple targeted genomic regions in various samples to detect concomitant mutations simultaneously, which can deal with maximal tumor genomic assessment.

Further Key Findings From the Report Suggest:

• Instruments are estimated to account for the leading share in the market throughout the forecast period owing to optimal availability of products for single-cell sequencing kits. The segment is poised to command about 58.0% of the overall revenue
• NGS (Next-Generation Sequencing) is the most promising technology segment owing to the launch of integrated & advanced platforms for single-cell analysis. The segment is projected to expand at a CAGR of 15.72% during the forecast period
• Circulating cells will hold the largest share throughout the forecast period owing to intensive research studies on circulating tumor cells in the area of cancer progressions and treatment
• Academic & research laboratories will be the dominant revenue contributor during the same period. The dominance can be attributed to presence of established genomic centers and their research initiatives in the space
• North America dominated the market owing to well-established administration support, investigations, and presence of substantial number of regional players
• Asia Pacific region is expected to exhibit the fastest growth over the forecast period owing to active participation of players, extensive research, and favorable government support
• Major players include F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific, Inc.; QIAGEN; Bio-Rad Laboratories; 10x Genomics; Novogene; Fludigim; BGI; Illumina, Inc.; Oxford Nanopore Technologies; and Pacific Biosciences. Companies are collaborating with private & public entities as well as academic institutions to accelerate advancements in the single-cell genome sequencing market. 

Recently, investigators at the Harvard University developed novel approaches such as in Drop & Drop-Seq. These methods are developed for isolation of thousands of cells and sequencing preparation. Moreover, academic and commercial investigators are consistently pushing boundaries & gradually shaping the outlook of the genomics sector.

Major players in the market include Bio-Rad Laboratories; 10x Genomics; Novogene; Fluidigm; BGI; Illumina, Inc.; Oxford Nanopore Technologies; Pacific Biosciences; Thermo Fisher Scientific, Inc.; QIAGEN; and F Hoffmann-La Roche Ltd.

Currently, key players are forming partnerships with other market players in order to enhance their product portfolios. Companies are also expanding their R&D, distribution, and management facilities in order to expand their business and to hold a competitive edge in the market.

Grand View Research has segmented the single-cell genome sequencing market on the basis of product type, Technology, workflow:

Single Cell Genome Sequencing Product Type Outlook (Revenue, USD Million, 2014 - 2025)

• Instruments
• Reagents

Single Cell Genome Sequencing Technology Outlook (Revenue, USD Million, 2014 - 2025)

• NGS
• PCR
• qPCR
• Microarray
• MDA

Single Cell Genome Sequencing Workflow Outlook (Revenue, USD Million, 2014 - 2025)

• Single-cell isolation
• Sample preparation
• Genomic analysis